Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 10-Q

 


 

x Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

 

For the Quarterly Period Ended June 30, 2004

 

OR

 

¨ Transition Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934

 

For the Transition Period From              to             

 

Commission file number 1-652

 


 

UNIVERSAL CORPORATION

(Exact name of registrant as specified in its charter)

 


 

Virginia   54-0414210

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

1501 North Hamilton Street,

Richmond, Virginia 23230

  804-359-9311
(Address of principal executive offices)   (Registrant’s telephone number)

 

Indicate by “X” mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No   ¨

 

Indicate by “X” mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).    Yes   x    No   ¨

 

As of August 1, 2004, the total number of shares of common stock outstanding was 25,532,406.

 



Table of Contents

UNIVERSAL CORPORATION

FORM 10-Q

TABLE OF CONTENTS

 

Item No.


        Page

     PART I - FINANCIAL INFORMATION     

1.

   Financial Statements    3

2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    14

3.

   Quantitative and Qualitative Disclosures About Market Risk    19

4.

   Controls and Procedures    21
     PART II - OTHER INFORMATION     

1.

   Legal Proceedings    22

6.

   Exhibits and Reports on Form 8-K    23
     Signatures    24

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

UNIVERSAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME AND RETAINED EARNINGS

Three Months Ended June 30, 2004, and September 30, 2003

(In thousands of dollars, except share and per share data)

 

     THREE MONTHS

 
    

June 30,

2004


   

September 30,

2003


 
     (Unaudited)  

Sales and other operating revenues

   $ 737,141     $ 786,601  

Costs and expenses

                

Cost of goods sold

     601,067       647,008  

Selling, general and administrative expenses

     94,849       79,939  
    


 


Operating income

     41,225       59,654  

Equity in pretax earnings of unconsolidated affiliates

     2,909       3,776  

Interest expense

     12,608       11,076  
    


 


Income before income taxes and other items

     31,526       52,354  

Income taxes

     12,453       18,847  

Minority interests

     (1,406 )     (921 )
    


 


Net income

   $ 20,479     $ 34,428  
    


 


Earnings per common share - basic

   $ 0.80     $ 1.38  
    


 


Earnings per common share - diluted

   $ 0.80     $ 1.37  
    


 


Retained earnings - beginning of period

   $ 679,202     $ 592,673  

Net income

     20,479       34,428  

Cash dividends declared ($.39 in 2004, $.36 in 2003)

     (9,951 )     (8,989 )

Purchase of common stock

     —         (3,268 )
    


 


Retained earnings - end of period

   $ 689,730     $ 614,844  
    


 


 

See accompanying notes.

 

3


Table of Contents

UNIVERSAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

 

    

June 30,

2004


   September 30,
2003


   March 31,
2004


     (Unaudited)    (Unaudited)     
ASSETS                     

Current

                    

Cash and cash equivalents

   $ 52,686    $ 57,183    $ 39,310

Accounts receivable, net

     430,736      408,213      432,546

Advances to suppliers, net

     113,913      122,991      140,758

Accounts receivable - unconsolidated affiliates

     6,545      5,622      6,156

Inventories - at lower of cost or market:

                    

Tobacco

     790,089      609,431      562,927

Lumber and building products

     150,045      140,299      138,423

Agri-products

     127,573      76,748      106,214

Other

     49,715      35,878      35,071

Prepaid income taxes

     10,061      5,819      9,635

Deferred income taxes

     15,146      5,995      16,908

Other current assets

     49,216      34,893      38,721
    

  

  

Total current assets

     1,795,725      1,503,072      1,526,669

Property, plant and equipment - at cost

                    

Land

     70,188      51,692      60,823

Buildings

     376,952      306,092      364,948

Machinery and equipment

     703,716      695,450      694,314
    

  

  

       1,150,856      1,053,234      1,120,085

Less accumulated depreciation

     574,783      524,234      559,217
    

  

  

       576,073      529,000      560,868

Other assets

                    

Goodwill and other intangibles

     133,844      132,472      134,664

Investments in unconsolidated affiliates

     89,043      93,559      94,460

Deferred income taxes

     61,758      45,436      62,489

Other noncurrent assets

     91,883      91,631      103,623
    

  

  

       376,528      363,098      395,236
    

  

  

Total assets

   $ 2,748,326    $ 2,395,170    $ 2,482,773
    

  

  

 

See accompanying notes.

 

4


Table of Contents

UNIVERSAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

 

     June 30,
2004


    September 30,
2003


    March 31,
2004


 
     (Unaudited)     (Unaudited)        
LIABILITIES AND SHAREHOLDERS’ EQUITY                         

Current

                        

Notes payable and overdrafts

   $ 394,375     $ 253,423     $ 244,031  

Accounts payable

     320,514       352,201       331,963  

Accounts payable - unconsolidated affiliates

     401       3,375       2,571  

Customer advances and deposits

     183,554       193,202       59,894  

Accrued compensation

     25,786       23,780       32,703  

Income taxes payable

     30,559       23,958       22,007  

Current portion of long-term obligations

     57,419       102,413       45,941  
    


 


 


Total current liabilities

     1,012,608       952,352       739,110  

Long-term obligations

     769,348       609,939       770,296  

Postretirement benefits other than pensions

     42,283       40,491       41,721  

Other long-term liabilities

     92,632       97,780       93,739  

Deferred income taxes

     32,484       12,392       43,691  
    


 


 


Total liabilities

     1,949,355       1,712,954       1,688,557  

Minority interests

     32,272       33,416       34,383  

Shareholders’ equity

                        

Preferred stock, no par value, authorized 5,000,000 shares, none issued or outstanding

                        

Common stock, no par value, authorized 100,000,000 shares, 25,532,406 issued and outstanding shares (24,983,745 at September 30, 2003, and 25,446,975 at March 31, 2004)

     111,896       95,169       112,505  

Retained earnings

     689,730       614,844       679,202  

Accumulated other comprehensive income (loss)

     (34,927 )     (61,213 )     (31,874 )
    


 


 


Total shareholders’ equity

     766,699       648,800       759,833  
    


 


 


Total liabilities and shareholders’ equity

   $ 2,748,326     $ 2,395,170     $ 2,482,773  
    


 


 


 

See accompanying notes.

 

5


Table of Contents

UNIVERSAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Three months ended June 30, 2004, and September 30, 2003

(In thousands of dollars)

 

     THREE MONTHS

 
    

June 30,

2003


   

September 30,

2003


 
     (Unaudited)  

CASH FLOWS FROM OPERATING ACTIVITIES:

                

Net income

   $ 20,479     $ 34,428  

Depreciation

     15,585       11,892  

Amortization

     848       792  

Other adjustments to reconcile net income to net cash provided by operating activities

     5,819       (4,354 )

Changes in operating assets and liabilities

     (112,017 )     9,866  
    


 


Net cash provided (used) by operating activities

     (69,286 )     52,624  

CASH FLOWS FROM INVESTING ACTIVITIES:

                

Purchase of property, plant and equipment

     (14,078 )     (19,500 )

Purchase of business, net of cash acquired

     (12,477 )     —    

Sales of property, plant, and equipment and other

     2,261       —    
    


 


Net cash used in investing activities

     (24,294 )     (19,500 )

CASH FLOWS FROM FINANCING ACTIVITIES:

                

Issuance (repayment) of short-term debt, net

     120,655       (12,300 )

Issuance of long-term debt

     —         2,900  

Repayment of long-term debt

     (4,550 )     (3,400 )

Issuance of common stock

     802       4,700  

Purchases of common stock

     —         (3,500 )

Dividends paid

     (9,951 )     (9,000 )
    


 


Net cash provided (used) in financing activities

     106,956       (20,600 )

Net increase in cash and cash equivalents

     13,376       12,524  

Cash and cash equivalents at beginning of year

     39,310       44,659  
    


 


Cash and cash equivalents at end of period

   $ 52,686     $ 57,183  
    


 


 

See accompanying notes.

 

6


Table of Contents

UNIVERSAL CORPORATION AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

 

NOTE 1. BASIS OF PRESENTATION

 

Universal Corporation, with its subsidiaries (the “Company” or “Universal”), has operations in tobacco, lumber and building products, and agri-products. Because of the seasonal nature of these businesses, the results of operations for any fiscal quarter will not necessarily be indicative of results to be expected for other quarters or a full fiscal year. All adjustments necessary to state fairly the results for the period have been included and were of a normal recurring nature. Certain amounts in prior year statements have been reclassified to conform to the current year presentation.

 

NOTE 2. CHANGE IN FISCAL YEAR END AND ELIMINATION OF REPORTING LAG FOR FOREIGN SUBSIDIARIES

 

The Company changed its fiscal year end from June 30 to March 31, effective March 31, 2004. In addition to better matching the fiscal reporting period with the crop and operating cycles of the Company’s largest operations, the change allowed the Company to eliminate the three-month reporting lag previously used by most of its foreign subsidiaries. All of the Company’s consolidated subsidiaries now have the same fiscal reporting period.

 

Throughout the fiscal year that will end on March 31, 2005, quarterly financial statements will include comparative information for the same sequential quarter of the prior year. Due to the year-end change, interim quarters in fiscal year 2005 will end three months earlier than the corresponding quarters in fiscal year 2004. Management believes this presentation provides the most appropriate comparison since foreign results, which represent the majority of the Company’s business, are generally compared for the same operating months in each year, due to the reporting lag in 2004. Comparisons of summarized historical financial information are provided in Note 11 that present 2004 data recast for the effect of eliminating the reporting lag; however, it is not practical to provide recast 2004 data for all information reported in the quarterly financial statements.

 

NOTE 3. ACCOUNTING PRONOUNCEMENTS

 

In December 2003, the Financial Accounting Standards Board (“FASB”) issued a revision of Statement of Financial Accounting Standards No. 132, “Employers’ Disclosures about Pensions and Other Postretirement Benefits” (“Statement No. 132”). The revised Statement No. 132 expanded the disclosure requirements for pension and postretirement benefits, and introduced new disclosures for interim financial periods. The Company adopted the provisions of the revised Statement No. 132 in fiscal year 2004 and has provided the required interim financial information for the first quarter of fiscal year 2005 in Note 10.

 

In May 2004, the FASB issued Staff Position No. 106-2 (“FSP No. 106-2”), “Accounting and Disclosure Requirements Related to the Medicare Prescription Drug Improvement an